NuGene International Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 10
Employees
  • Stock Symbol
  • NUGN
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.03
  • (As of Friday Closing)

NuGene International General Information

Description

NuGene International Inc is a shell company.

Contact Information

Formerly Known As
NuGene
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Personal Products
Stock Exchange
PINX
Primary Office
  • 17912 Cowan Street
  • Irvine, CA 92614
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NuGene International Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 1.32M

NuGene International Financials Summary

In Thousands,
USD
TTM 31-Dec-2016 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014
EV 15,842 15,842 44,832
Revenue 509 509 2,085 723
EBITDA (10,221) (10,221) (5,123) (262)
Net Income (11,817) (11,817) (5,219) (313)
Total Assets 325 325 878 1,860
Total Debt 2,801 2,801 843
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NuGene International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NuGene International‘s full profile, request access.

Request a free trial

NuGene International Patents

NuGene International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180110804-A1 Burn, scar, and wound treatment creams Abandoned 04-Feb-2015 000000000
US-20080317733-A1 Cosmeceutical compositions and methods with biologically active ingredients Abandoned 20-Jun-2007 0000000000 0
US-20080317835-A1 Personalized nutrient deficiency assay methods Abandoned 20-Jun-2007 000000000 0
US-20080317822-A1 Methods for delivery of nanosome encapsulated agents Abandoned 20-Jun-2007 000000000 0
US-20080317734-A1 Nutraceutical compositions and methods with biologically active ingredients Abandoned 20-Jun-2007 A61K38/1841 0
To view NuGene International’s complete patent history, request access »

NuGene International Executive Team (4)

Name Title Board Seat Contact Info
Steven Carlson Chief Executive Officer
John Ohanesian Chief Strategic Advisor
Saeed Kharazmi MD Co-Founder, Director & Chairman
You’re viewing 3 of 4 executive team members. Get the full list »

NuGene International Board Members (1)

Name Representing Role Since
00000 00000000 00 NuGene International Co-Founder, Director & Chairman 000 0000
To view NuGene International’s complete board members history, request access »

NuGene International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuGene International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NuGene International‘s full profile, request access.

Request a free trial

NuGene International Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 17-Mar-2015 0000000000 Personal Products 000 00000
Bling Marketing 29-Dec-2014 Merger/Acquisition Luxury Goods
To view NuGene International’s complete acquisitions history, request access »